NEW YORK (GenomeWeb News) – Rodney Markin has joined Trovagene's board of directors, and Chris McGuigan has resigned from the company's board to focus on other opportunities, Trovagene said this week.

Markin is chairman of Transgenomic, chief technology officer and associate vice chancellor for business development at the University of Nebraska Medical Center, and a professor of pathology and microbiology and surgery at the university.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.